Human prolactin promotes human secondary immunoglobulin response in human/SCID mouse chimeras

Clinical and Vaccine Immunology

Volumn 14, Issue 1, 2007, Pages 60-64

  Zhang, Jian ^a   Sun, Rui ^b   Tian, Zhigang ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; DIPHTHERIA TETANUS VACCINE; IMMUNOGLOBULIN; PROLACTIN; RECOMBINANT PROLACTIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHIMERA; DRUG EFFECT; HORMONE ACTION; HUMAN; HUMAN CELL; LYMPH NODE; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; T LYMPHOCYTE; THYMUS; ANIMAL; CYTOTOXICITY; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; PROLACTIN; RECOMBINANT PROTEINS;

EID: 34247882157     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00244-06     Document Type: Article

References (35)

1. Agus, D. B., C. D. Surh, and J. Sprent. 1991. Reentry of T cells to the adult thymus is restricted to activated T cells. J. Exp. Med. 173:1039-1046.
2. Allen, S. H., G. C. Sharp, G. Wang, C. Conley, Y. Takeda, S. E. Conroy, and S. E. Walker. 1996. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5:30-37.
3. Alvarez-Nemegyei, J., A. Cobarrubias-Cobos, F. Escalante-Triay, J. Sosa-Munoz, J. M. Miranda, and L. J. Jara. 1998. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 7:414-419.
4. Bazan, J. F. 1990. Structural design and molecular evolution of cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934-6938.
5. Bellone, G., M. Geuna, A. Carbone, S. Silvestri, R. Foa, G. Emanuelli, and L. Matera. 1995. Regulatory action of prolactin on the in vitro growth of CD34 positive human hemopoietic progenitor cells. J. Cell Physiol. 163:221-231.
6. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
7. Cesano, A., E. Oberholtzer, M. Contarini, M. Geuna, G. Bellone, and L. Meteral. 1991. Independent and synergistic effect of interleukin-2 and prolactin in development of T- and NK-derived LAK effectors. Adv. Neuroimmunol. 1:158-172.
8. Gala, R. R., and E. M. Shevach. 1993. Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc. Soc. Exp. Biol. Med. 204:224-230.
9. Gutierrez, M. A., J. F. Molina, L. J. Jara, M. L. Cuellar, C. Garcia, S. Gutierrez-Urena, A. Gharavi, and L. R. Espinoza. 1995. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 4:348-352.
10. Hartmann, D. P., J. W. Holaday, and E. W. Bernton. 1989. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3:2194-2202.
11. Jara, L. J., C. Gomez-Sanchez, L. H. Silveira, P. Martinez-Osuna, F. B. Vasey, and L. R. Espinoza. 1992. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am. J. Med. Sci. 303:222-226.
12. Larrea, F., A. Martinez-Castillo, V. Cabrera, J. Alcocer-Varela, G. Queipo, C. Carino, and D. Alarcon-Segovia. 1997. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and non-stimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J. Clin. Endocrinol. Metab. 82:3664-3669.
13. Lavalle, C., A. Graef, V. Baca, M. Ramirez-Lacayo, F. Blanco-Favela, and O. Ortiz. 1993. Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus. Lupus 2:71-75.
14. McMurray, R. W. 1996. Prolactin and systemic lupus erythematosus. Ann. Med. Interne 147:253-258.
15. McMurray, R. W., D. Weidensaul, S. H. Allen, and S. E. Walker. 1995. Efficacy of bromocriptine in an open label therapeutic trial for SLE. J. Rheumatol. 22:2084-2091.
16. Morales, P., M. V. Carretero, H. Geronimo, S. G. Copin, M. L. Gaspar, M. A. Marcos, and J. Martin-Perez. 1999. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ. 10:583-589.
17. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
18. Mosier, D. E. 1991. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv. Immunol. 50:303-325.
19. Murphy, W. J., R. Hallgeir, and D. L. Longo. 1995. Effects of growth hormone and prolactin: immune development and function. Life Sci. 57:1-14.
20. Murphy, W. J., S. K. Durum, M. R. Anver, and D. L. Longo. 1992. Immunologic and haematologic effects of neuroendocrine hormone: studies on DW/J dwarf mice. J. Immunol. 148:3799-3805.
21. Murphy, W. J., M. Bennett, M. R. Anver, M. Baseler, and D. L. Longo. 1992. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur. J. Immunol. 22:1421-1427.
22. Murphy, W. J., K. C. Conlon, T. J. Sayers, R. H. Wiltrout, T. C. Back, J. R. Ortaldo, and D. L. Longo. 1993. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J. Immunol. 150:3634-3642.
23. Murphy, W. J., S. K. Durum, and D. L. Longo. 1992. Human growth hormone promotes engraftment of murine or human T cell into severe combined immune deficient mice. Proc. Natl. Acad. Sci. USA 89:4481-4485.
24. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
25. Peeva, E., D. Michael, J. Cleary, J. Rice, X. Chen, and B. Diamond. 2003. Prolactin modulates the naive B cell repertoire. J. Clin. Investig. 111:275-283.
26. Sun, R., J. Zhang, C. Zhang, J. H. Zhang, S. J. Liang, A. Y. Sun, J. F. Wang, and Z. G. Tian. 2004. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice. Cell. Mol. Immunol. 1:129-136.
27. Sun, R., H. Wei, J. Zhang, A. Li, W. Zhang, and Z. Tian. 2002-2003. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo. Neuroimmunomodulation 10:169-176.
28. Tissot, J. D., P. Schneider, M. Schapira, and M. A. Duchosal. 1996. Human immunoglobulins produced in huPBL-SCID mice are polyclonal early after xenotransplantation. Cell. Immunol. 167:241-248.
29. Venkatesh, J., E. Peeva, X. Xu, and B. Diamond. 2006. Cutting edge. Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J. Immunol. 176:3311-3314.
30. Vidaller, A., L. Llorente, F. Larrea, J. P. Mendez, J. Alcocer-Varela, and D. Alarcon-Segovia. 1986. T cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clin. Immunol. Immunopathol. 38:337-343.
31. Walker, S. E., R. W. McMurray, J. M. Houri, S. H. Allen, D. Keisler, G. C. Sharp, and J. A. Schlechte. 1998. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 840:762-772.
32. Walker, W., and G. Gallagher. 1994. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice. Immunology 83:163-170.
33. Welniak, L. A., Z. G. Tian, R. Sun, J. R. Keller, S. Richards, F. W. Ruscetti, and W. J. Murphy. 2000. Effects of growth hormone and prolactin on hematopoiesis. Leuk. Lymphoma 38:435-445.
34. Woody, M. A., L. A. Welniak, R. Sun, Z. G. Tian, M. Henry, S. Richards, A. Raziuddin, D. L. Longo, and W. J. Murphy. 1999. Prolactin exerts hematopoietic growth promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp. Hematol. 27:811-816.
35. Zhang, J., R. Sun, H. Wei, and Z. Tian. 2005. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft. Int. Immunopharmacol. 5:417-425.